8-K Announcements
6May 4, 2026·SEC
Mar 31, 2026·SEC
Mar 23, 2026·SEC
Crawford & Company (CRD-A) fundamental analysis — strengths, weaknesses & financial health based on data analysis
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Crawford & Company (CRD-A) stock price & volume — 10-year historical chart
Crawford & Company (CRD-A) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Crawford & Company (CRD-A) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 4, 2026 | $0.16vs $0.21-22.6% | $310Mvs $308M+0.4% |
| Q2 2026 | Mar 2, 2026 | $0.15vs $0.23-33.8% | $309Mvs $333M-7.2% |
| Q4 2025 | Nov 3, 2025 | $0.25vs $0.16+54.9% | $322Mvs $333M-3.1% |
| Q3 2025 | Aug 4, 2025 | $0.25vs $0.27-6.4% | $335Mvs $350M-4.5% |
Crawford & Company (CRD-A) competitors in Claims and cost containment services — business model, growth, and fundamentals comparison
Crawford & Company (CRD-A) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Crawford & Company (CRD-A) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.16B | 1.12B | 1.05B | 1.02B | 1.14B | 1.23B | 1.32B | 1.34B | 1.31B | 1.3B |
| Revenue Growth % | -1.18% | -3.5% | -6.71% | -3% | 12.11% | 8.08% | 6.96% | 1.83% | -2% | -3.95% |
| Medical Costs & Claims | 842.17M | 808M | 752.77M | 737.32M | 847.43M | 924.87M | 957.85M | 973.42M | 992.21M | 956.47M |
| Medical Cost Ratio % | 72.37% | 71.95% | 71.86% | 72.56% | 74.39% | 75.12% | 72.73% | 72.59% | 75.5% | 73.65% |
| Gross Profit | 321.54M▲ 0% | 314.97M▼ 2.0% | 294.85M▼ 6.4% | 278.88M▼ 5.4% | 291.8M▲ 4.6% | 306.35M▲ 5.0% | 359.07M▲ 17.2% | 367.55M▲ 2.4% | 321.9M▼ 12.4% | 342.13M▲ 0% |
| Gross Margin % | 27.63% | 28.05% | 28.14% | 27.44% | 25.61% | 24.88% | 27.27% | 27.41% | 24.5% | 26.35% |
| Gross Profit Growth % | -1.81% | -2.04% | -6.39% | -5.42% | 4.64% | 4.99% | 17.21% | 2.36% | -12.42% | - |
| Operating Expenses | 251.75M | 242.42M | 227.17M | 218.95M | 244.85M | 255.75M | 286.51M | 299.66M | 245.69M | 275.99M |
| OpEx / Revenue % | 21.63% | 21.59% | 21.68% | 21.55% | 21.49% | 20.77% | 21.76% | 22.35% | 18.7% | 21.25% |
| Depreciation & Amortization | 41.66M | 44.08M | 40.51M | 40.11M | 40.18M | 36.1M | 35.74M | 36.2M | 40.04M | 39.98M |
| Combined Ratio % | 94% | 93.54% | 93.54% | 94.1% | 95.88% | 95.89% | 94.49% | 94.94% | 94.2% | 94.91% |
| Operating Income | 69.8M▲ 0% | 72.55M▲ 3.9% | 67.68M▼ 6.7% | 59.92M▼ 11.5% | 46.95M▼ 21.6% | 50.6M▲ 7.8% | 72.57M▲ 43.4% | 67.88M▼ 6.5% | 76.21M▲ 12.3% | 66.14M▲ 0% |
| Operating Margin % | 6% | 6.46% | 6.46% | 5.9% | 4.12% | 4.11% | 5.51% | 5.06% | 5.8% | 5.09% |
| Operating Income Growth % | -13.9% | 3.95% | -6.71% | -11.47% | -21.65% | 7.78% | 43.4% | -6.45% | 12.26% | - |
| EBITDA | 111.45M | 116.63M | 108.2M | 100.03M | 87.13M | 86.7M | 108.31M | 104.08M | 116.25M | 106.12M |
| EBITDA Margin % | 9.58% | 10.39% | 10.33% | 9.84% | 7.65% | 7.04% | 8.22% | 7.76% | 8.85% | 8.17% |
| Interest Expense | 9.91M | 11.4M | 11.52M | 8.19M | 6.98M | 10.97M | 19.81M | 20.3M | 17.97M | 15.81M |
| Non-Operating Income | 17.63M | 17.02M | 32.53M | 0 | -3.9M | 34.59M | 5.4M | 6.47M | 23.64M | 17.67M |
| Pretax Income | 42.26M▲ 0% | 44.13M▲ 4.4% | 23.64M▼ 46.4% | 39.09M▲ 65.4% | 43.86M▲ 12.2% | 5.05M▼ 88.5% | 47.36M▲ 838.5% | 41.11M▼ 13.2% | 34.6M▼ 15.8% | 32.67M▲ 0% |
| Pretax Margin % | 3.63% | 3.93% | 2.26% | 3.85% | 3.85% | 0.41% | 3.6% | 3.07% | 2.63% | 2.52% |
| Income Tax | 15.04M | 18.54M | 14.11M | 12.01M | 13.32M | 23.58M | 17.1M | 14.58M | 14.92M | 14.82M |
| Effective Tax Rate % | 35.59% | 42.02% | 59.7% | 30.73% | 30.36% | 467.26% | 36.1% | 35.47% | 43.13% | 45.36% |
| Net Income | 27.66M▲ 0% | 25.98M▼ 6.1% | 12.48M▼ 51.9% | 28.3M▲ 126.6% | 30.69M▲ 8.5% | -18.3M▼ 159.6% | 30.61M▲ 267.2% | 26.6M▼ 13.1% | 19.63M▼ 26.2% | 17.86M▲ 0% |
| Net Margin % | 2.38% | 2.31% | 1.19% | 2.78% | 2.69% | -1.49% | 2.32% | 1.98% | 1.49% | 1.37% |
| Net Income Growth % | -23.08% | -6.1% | -51.94% | 126.64% | 8.47% | -159.64% | 267.22% | -13.11% | -26.18% | -41.35% |
| EPS (Diluted) | 0.52▲ 0% | 0.50▼ 3.8% | 0.18▼ 64.0% | 0.54▲ 200.0% | 0.57▲ 5.6% | -0.37▼ 164.9% | 0.62▲ 267.6% | 0.53▼ 14.5% | 0.39▼ 26.4% | 0.36▲ 0% |
| EPS Growth % | -22.39% | -3.85% | -64% | 200% | 5.56% | -164.91% | 267.57% | -14.52% | -26.42% | -40.12% |
| EPS (Basic) | 0.53 | 0.51 | 0.18 | 0.54 | 0.58 | -0.37 | 0.63 | 0.54 | 0.40 | - |
| Diluted Shares Outstanding | 53.2M | 51.96M | 54.06M | 53.38M | 53.98M | 49.47M | 49.59M | 49.74M | 50.07M | 49.4M |
Crawford & Company (CRD-A) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 787.94M | 701.44M | 760.01M | 752.98M | 852.64M | 791.51M | 799.2M | 803.75M | 764.3M | 771.65M |
| Asset Growth % | 7.08% | -10.98% | 8.35% | -0.92% | 13.23% | -7.17% | 0.97% | 0.57% | -4.91% | -5.9% |
| Total Investment Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.44M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 370.37M | 320.85M | 315.21M | 302M | 345.92M | 351.27M | 369.35M | 374.23M | 352.41M | 186.64M |
| Cash & Equivalents | 54.01M | 53.12M | 51.8M | 44.66M | 53.23M | 46.01M | 58.36M | 55.41M | 64.08M | 64.44M |
| Receivables | 282.92M | 239.41M | 239.93M | 227.86M | 258.12M | 276.48M | 247.97M | 278.48M | 246.97M | 918.71M |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 6.02M | 917K | 41.36M | 0 |
| Goodwill & Intangibles | 283.89M | 254.12M | 222.17M | 208.73M | 289.9M | 247.64M | 255.28M | 262.77M | 255.73M | 1.04B |
| Goodwill | 96.92M | 96.89M | 80.64M | 66.54M | 116.53M | 76.62M | 76.72M | 76.37M | 76.57M | 0 |
| Intangible Assets | 186.97M | 157.23M | 141.53M | 142.2M | 173.37M | 171.01M | 178.56M | 186.4M | 179.16M | 254.82M |
| PP&E (Net) | 41.66M | 34.3M | 133.78M | 145.72M | 133.09M | 121.14M | 111.36M | 99.36M | 82.97M | 0 |
| Other Assets | 67.66M | 70.02M | 70.88M | 70.94M | 62.46M | 51.89M | 36.97M | 42.09M | 48.5M | 319.75M |
| Total Liabilities | 594.2M | 520.5M | 595.14M | 566.06M | 641.24M | 668.13M | 659.37M | 648.2M | 592.87M | 597.19M |
| Total Debt | 225.67M | 190.41M | 294.78M | 239.57M | 288.67M | 346.4M | 311.53M | 309.49M | 270.27M | 271.1M |
| Net Debt | 171.66M | 137.29M | 242.98M | 194.91M | 235.44M | 300.39M | 253.16M | 254.08M | 206.19M | 271.1M |
| Long-Term Debt | 199.64M | 167.12M | 148.35M | 111.28M | 163.98M | 211.64M | 194.27M | 200.24M | 150.55M | 200.68M |
| Short-Term Debt | 24.64M | 23.2M | 28.53M | 1.57M | 10.62M | 26.97M | 14.73M | 17.74M | 38.45M | 70.42M |
| Total Current Liabilities | 256.59M | 225.31M | 236.26M | 242.79M | 303.86M | 279.49M | 299.29M | 299.73M | 309.57M | 323.25M |
| Accounts Payable | 49.3M | 37.83M | 34.38M | 41.54M | 48.47M | 50.85M | 45.11M | 50.6M | 39.77M | 59.24M |
| Deferred Revenue | 37.79M | 30.96M | 28.29M | 27.23M | 32.12M | 29.28M | 35.54M | 36.13M | 33.83M | 33.74M |
| Other Current Liabilities | 105.02M | 97.69M | 79.81M | 93.24M | 109.24M | 91.9M | 131.08M | 129.18M | 127.97M | 159.85M |
| Deferred Taxes | 1000K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 114.63M | 106.35M | 99.32M | 94.14M | 60.88M | 67.47M | 62.84M | 57.8M | 55.91M | 73.27M |
| Total Equity | 193.74M▲ 0% | 180.95M▼ 6.6% | 164.88M▼ 8.9% | 186.93M▲ 13.4% | 211.4M▲ 13.1% | 123.38M▼ 41.6% | 139.83M▲ 13.3% | 155.55M▲ 11.2% | 171.43M▲ 10.2% | 174.46M▲ 0% |
| Equity Growth % | 21.65% | -6.6% | -8.88% | 13.37% | 13.09% | -41.64% | 13.34% | 11.24% | 10.21% | 53.68% |
| Shareholders Equity | 182.32M | 171.29M | 159.32M | 186.94M | 211.97M | 124.54M | 141.62M | 157.21M | 173.09M | 176.27M |
| Minority Interest | 11.42M | 9.66M | 5.56M | -11K | -568K | -1.17M | -1.79M | -1.66M | -1.66M | -1.82M |
| Retained Earnings | 269.69M | 273.61M | 249.55M | 265.25M | 266.37M | 213.09M | 228.56M | 237.95M | 233.71M | 229.96M |
| Common Stock | 55.94M | 55.34M | 53.28M | 53.36M | 51.81M | 48.61M | 49.08M | 49.27M | 48.87M | 48.69M |
| Accumulated OCI | -196.48M | -216.45M | -206.91M | -198.86M | -180.44M | -215.32M | -218.62M | -217.13M | -201.74M | -193.62M |
| Return on Equity (ROE) | 15.67% | 13.87% | 7.22% | 16.09% | 15.41% | -10.94% | 23.26% | 18.01% | 12.01% | 10.1% |
| Return on Assets (ROA) | 3.63% | 3.49% | 1.71% | 3.74% | 3.82% | -2.23% | 3.85% | 3.32% | 2.5% | 2.28% |
| Equity / Assets | 24.59% | 25.8% | 21.69% | 24.82% | 24.79% | 15.59% | 17.5% | 19.35% | 22.43% | 22.61% |
| Debt / Equity | 1.16x | 1.05x | 1.79x | 1.28x | 1.37x | 2.81x | 2.23x | 1.99x | 1.58x | 1.58x |
| Book Value per Share | 3.64 | 3.48 | 3.05 | 3.50 | 3.92 | 2.49 | 2.82 | 3.13 | 3.42 | 3.53 |
| Tangible BV per Share | -1.69 | -1.41 | -1.06 | -0.41 | -1.45 | -2.51 | -2.33 | -2.16 | -1.68 | -1.63 |
Crawford & Company (CRD-A) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 40.76M | 52.42M | 75.22M | 93.18M | 54.32M | 27.63M | 103.79M | 51.62M | 101.85M | 101.85M |
| Operating CF Growth % | -58.77% | 28.61% | 43.49% | 23.88% | -41.7% | -49.13% | 275.59% | -50.27% | 97.31% | 403.64% |
| Operating CF / Revenue % | 3.5% | 4.67% | 7.18% | 9.17% | 4.77% | 2.24% | 7.88% | 3.85% | 7.75% | 7.84% |
| Net Income | 27.22M | 25.59M | 9.53M | 27.07M | 30.55M | -18.53M | 30.61M | 26.53M | 19.68M | 17.86M |
| Depreciation & Amortization | 41.66M | 44.08M | 40.51M | 40.11M | 40.18M | 36.1M | 35.74M | 36.2M | 40.04M | 39.98M |
| Stock-Based Compensation | 6.66M | 6.2M | 4.11M | 4.38M | 7.58M | 4.92M | 5.6M | 5.77M | 5.19M | 266K |
| Deferred Taxes | -2.36M | 7.95M | 3.04M | -9.01M | -2.99M | 7.4M | -12.28M | -2.53M | -3.33M | 0 |
| Other Non-Cash Items | 19.6M | 21.33M | 17.48M | 3.91M | 104K | 38.24M | 4.32M | -997K | 3.25M | 2.23M |
| Working Capital Changes | -52.02M | -52.72M | 544K | 26.7M | -21.1M | -40.49M | 39.79M | -13.34M | 37.01M | 56.68M |
| Cash from Investing | -81.87M | 6.45M | -23.42M | -27.04M | -70.83M | -57.88M | -36.6M | -41.65M | -36.21M | -34.95M |
| Capital Expenditures | -44.91M | -30.02M | -8.69M | -37.38M | -9.22M | -6.84M | -4.89M | 0 | 0 | -21.59M |
| Acquisitions | -36.03M | 36.69M | -2.3M | 9.98M | -46.4M | -26.31M | 0 | 0 | 0 | 0 |
| Purchase of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sale/Maturity of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing | -926K | -218K | -12.44M | 358K | -15.2M | -24.73M | -31.71M | -41.65M | -36.21M | -13.36M |
| Cash from Financing | 10.34M | -58.74M | -53.41M | -74.37M | 24.66M | 25.94M | -54.68M | -12.86M | -57.62M | -77.2M |
| Dividends Paid | -13.7M | -13.53M | -13.17M | -9.64M | -12.66M | -11.84M | -12.7M | -13.76M | -14.33M | -14.54M |
| Share Repurchases | -7.42M | -11.52M | -26.21M | -2.67M | -19.13M | -26.75M | -2.73M | -3.87M | -10.51M | -16.03M |
| Stock Issued | 1.15M | 1.39M | 0 | 0 | 0 | 0 | 0 | 0 | 2.04M | 2.04M |
| Debt Issuance (Net) | -1000K | -1000K | -1000K | -1000K | 1000K | 1000K | -1000K | 1000K | -1000K | -2M |
| Other Financing | 34.63M | -320K | 819K | 13K | -4.12M | -2.87M | -5.75M | -3.62M | -5M | 4.57M |
| Net Change in Cash | -27.56M▲ 0% | -892K▲ 96.8% | -1.32M▼ 47.6% | -7.15M▼ 442.6% | 9.03M▲ 226.4% | -7.04M▼ 178.0% | 12.9M▲ 283.1% | -3.22M▼ 124.9% | 8.22M▲ 355.5% | 6.42M▲ 0% |
| Exchange Rate Effect | 3.21M | -1.02M | 293K | 1.08M | 881K | -2.74M | 386K | -326K | 198K | 1.55M |
| Cash at Beginning | 81.57M | 54.01M | 53.12M | 51.8M | 44.66M | 53.69M | 46.65M | 59.55M | 56.33M | 64.55M |
| Cash at End | 54.01M | 53.12M | 51.8M | 44.66M | 53.69M | 46.65M | 59.55M | 56.33M | 64.55M | 64.44M |
| Free Cash Flow | -4.15M▲ 0% | 22.4M▲ 639.2% | 54.09M▲ 141.5% | 55.8M▲ 3.2% | 23.37M▼ 58.1% | -6.96M▼ 129.8% | 67.19M▲ 1064.7% | 9.97M▼ 85.2% | 94.83M▲ 851.0% | 109.1M▲ 0% |
| FCF Growth % | -105.96% | 639.22% | 141.49% | 3.15% | -58.12% | -129.81% | 1064.74% | -85.16% | 850.99% | 216.01% |
| FCF Margin % | -0.36% | 1.99% | 5.16% | 5.49% | 2.05% | -0.57% | 5.1% | 0.74% | 7.22% | 8.4% |
| FCF per Share | -0.08 | 0.43 | 1 | 1.05 | 0.43 | -0.14 | 1.35 | 0.2 | 1.89 | 1.89 |
Crawford & Company (CRD-A) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 94% | 93.54% | 93.54% | 94.1% | 95.88% | 95.89% | 94.49% | 94.94% | 94.2% | 94.91% |
| Medical Cost Ratio | 72.37% | 71.95% | 71.86% | 72.56% | 74.39% | 75.12% | 72.73% | 72.59% | 75.5% | 73.65% |
| Return on Equity (ROE) | 15.67% | 13.87% | 7.22% | 16.09% | 15.41% | -10.94% | 23.26% | 18.01% | 12.01% | 10.1% |
| Return on Assets (ROA) | 3.63% | 3.49% | 1.71% | 3.74% | 3.82% | -2.23% | 3.85% | 3.32% | 2.5% | 2.28% |
| Equity / Assets | 24.59% | 25.8% | 21.69% | 24.82% | 24.79% | 15.59% | 17.5% | 19.35% | 22.43% | 22.61% |
| Book Value / Share | 3.64 | 3.48 | 3.05 | 3.5 | 3.92 | 2.49 | 2.82 | 3.13 | 3.42 | 3.53 |
| Debt / Equity | 1.16x | 1.05x | 1.79x | 1.28x | 1.37x | 2.81x | 2.23x | 1.99x | 1.58x | 1.58x |
| Revenue Growth | -1.18% | -3.5% | -6.71% | -3% | 12.11% | 8.08% | 6.96% | 1.83% | -2% | -3.95% |
Crawford & Company (CRD-A) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 4, 2026·SEC
Mar 31, 2026·SEC
Mar 23, 2026·SEC
Crawford & Company (CRD-A) stock FAQ — growth, dividends, profitability & financials explained
Crawford & Company (CRD-A) saw revenue decline by 2.0% over the past year.
Yes, Crawford & Company (CRD-A) is profitable, generating $17.9M in net income for fiscal year 2025 (1.5% net margin).
Yes, Crawford & Company (CRD-A) pays a dividend with a yield of 2.97%. This makes it attractive for income-focused investors.
Crawford & Company (CRD-A) has a return on equity (ROE) of 12.0%. This is reasonable for most industries.
Crawford & Company (CRD-A) has a combined ratio of 94.2%. A ratio below 100% indicates underwriting profitability.
Crawford & Company (CRD-A) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates